NVS Competitors & Alternatives
Compare Novartis AG ADR with similar stocks in the same industry
Drug Manufacturers - General
NVS
Main Stock$156.15
Tradestie Score
56
Market Cap
$254.99B
P/E Ratio
24.0
Revenue Growth
0.0%
Analyst Upside
-0.5%
Top Competitors
17 stocks in Drug Manufacturers - General| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
JNJ
Johnson & Johnson
|
$256.35
|
$448.07B | 30.8 | 53 | Compare |
|
ABBV
ABBVIE INC.
|
$250.94
|
$431.71B | 130.0 | 52 | Compare |
|
NVO
Novo-Nordisk A/S
|
$47.08
|
$262.92B | 12.4 | 39 | Compare |
|
AZN
AstraZeneca PLC
|
$169.64
|
$261.56B | 26.0 | 56 | Compare |
|
MRK
Merck & Co., Inc.
|
$130.20
|
$225.13B | 36.8 | 56 | Compare |
|
AMGN
Amgen Inc
|
$385.16
|
$160.70B | 27.0 | 56 | Compare |
|
PFE
Pfizer Inc.
|
$25.01
|
$154.70B | 19.0 | 56 | Compare |
|
GILD
Gilead Sciences Inc
|
$130.21
|
$137.92B | 18.1 | 54 | Compare |
|
SNY
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
|
$43.08
|
$121.27B | 19.9 | 46 | Compare |
|
BMY
Bristol-Myers Squibb Co.
|
$65.31
|
$96.54B | 18.2 | 51 | Compare |
More NVS Analysis
Data updated: Aug 03, 2026 | Industry: Drug Manufacturers - General (SIC 2834)
17 stocks in this industry